COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abeona Therapeutics Inc. | COM | 00289Y107 | 4,637 | 1,590,686 | SH | | SOLE | | 1,590,686 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 2,031,115 | 41,904,586 | SH | | SOLE | | 41,904,586 | 0 | 0 |
Acceleron Pharma Inc. | COM | 00434H108 | 2,572 | 27,000 | SH | | SOLE | | 27,000 | 0 | 0 |
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 442 | 172,630 | SH | | SOLE | | 172,630 | 0 | 0 |
Adaptive Biotechnologies Corporation | COM | 00650F109 | 22,426 | 463,539 | SH | | SOLE | | 463,539 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 66,819 | 6,675,181 | SH | | SOLE | | 6,675,181 | 0 | 0 |
ADC Therapeutics SA | SHS | H0036K147 | 78,992 | 1,687,500 | SH | | SOLE | | 1,687,500 | 0 | 0 |
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 40,511 | 4,379,592 | SH | | SOLE | | 4,379,592 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 923 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Aimmune Therapeutics, Inc. | COM | 00900T107 | 11,261 | 673,908 | SH | | SOLE | | 673,908 | 0 | 0 |
Albireo Pharma, Inc. | COM | 01345P106 | 9,776 | 369,047 | SH | | SOLE | | 369,047 | 0 | 0 |
Alector, Inc. | COM | 014442107 | 6,843 | 280,000 | SH | | SOLE | | 280,000 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 983,312 | 8,760,794 | SH | | SOLE | | 8,760,794 | 0 | 0 |
Alkermes plc | SHS | G01767105 | 24,154 | 1,244,744 | SH | | SOLE | | 1,244,744 | 0 | 0 |
Allakos Inc. | COM | 01671P100 | 52,851 | 735,469 | SH | | SOLE | | 735,469 | 0 | 0 |
Altimmune, Inc. | COM | 02155H200 | 22,572 | 2,107,600 | SH | | SOLE | | 2,107,600 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR | 023111206 | 238,717 | 34,496,685 | SH | | SOLE | | 34,496,685 | 0 | 0 |
AnaptysBio, Inc. | COM | 032724106 | 11,476 | 513,677 | SH | | SOLE | | 513,677 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | COM | 03753U106 | 29,281 | 896,551 | SH | | SOLE | | 896,551 | 0 | 0 |
Applied Therapeutics, Inc. | COM | 03828A101 | 2,384 | 65,934 | SH | | SOLE | | 65,934 | 0 | 0 |
Aravive, Inc. | COM | 03890D108 | 2,841 | 244,055 | SH | | SOLE | | 244,055 | 0 | 0 |
Arcus Biosciences, Inc. | COM | 03969F109 | 3,007 | 121,534 | SH | | SOLE | | 121,534 | 0 | 0 |
argenx SE | SPONSORED ADR | 04016X101 | 229,635 | 1,019,557 | SH | | SOLE | | 1,019,557 | 0 | 0 |
ARYA Sciences Acquisition Corp. | SHS CL A | G3165V109 | 2,361 | 150,000 | SH | | SOLE | | 150,000 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 501,421 | 3,390,270 | SH | | SOLE | | 3,390,270 | 0 | 0 |
Assembly Biosciences, Inc. | COM | 045396108 | 35,951 | 1,541,618 | SH | | SOLE | | 1,541,618 | 0 | 0 |
Atreca, Inc. | CL A COM | 04965G109 | 75,177 | 3,532,760 | SH | | SOLE | | 3,532,760 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 27,656 | 1,701,929 | SH | | SOLE | | 1,701,929 | 0 | 0 |
Autolus Therapeutics plc | SPON ADS | 05280R100 | 7,785 | 485,624 | SH | | SOLE | | 485,624 | 0 | 0 |
Axsome Therapeutics, Inc. | COM | 05464T104 | 83,083 | 1,009,757 | SH | | SOLE | | 1,009,757 | 0 | 0 |
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 2,218,840 | 11,777,285 | SH | | SOLE | | 11,777,285 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 1,851 | 249,123 | SH | | SOLE | | 249,123 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 65,597 | 13,766,405 | SH | | SOLE | | 13,766,405 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 936,064 | 7,589,294 | SH | | SOLE | | 7,589,294 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 16,176 | 265,000 | SH | | SOLE | | 265,000 | 0 | 0 |
Burning Rock Biotech Limited | SPONSORED ADS | 12233L107 | 6,753 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
Cabaletta Bio, Inc. | COM | 12674W109 | 7,089 | 636,363 | SH | | SOLE | | 636,363 | 0 | 0 |
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 2,310 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 90,507 | 13,713,195 | SH | | SOLE | | 13,713,195 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 54,388 | 945,221 | SH | | SOLE | | 945,221 | 0 | 0 |
Chiasma, Inc. | COM | 16706W102 | 5,093 | 946,701 | SH | | SOLE | | 946,701 | 0 | 0 |
Constellation Pharmaceuticals, Inc. | COM | 210373106 | 4,007 | 133,333 | SH | | SOLE | | 133,333 | 0 | 0 |
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 5,569 | 317,857 | SH | | SOLE | | 317,857 | 0 | 0 |
CymaBay Therapeutics, Inc. | COM | 23257D103 | 5,315 | 1,522,792 | SH | | SOLE | | 1,522,792 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 64,157 | 14,614,264 | SH | | SOLE | | 14,614,264 | 0 | 0 |
Denali Therapeutics Inc. | COM | 24823R105 | 2,536 | 104,900 | SH | | SOLE | | 104,900 | 0 | 0 |
Dicerna Pharmaceuticals, Inc. | COM | 253031108 | 3,031 | 119,335 | SH | | SOLE | | 119,335 | 0 | 0 |
Exact Sciences Corporation | COM | 30063P105 | 160,503 | 1,846,139 | SH | | SOLE | | 1,846,139 | 0 | 0 |
Evofem Biosciences, Inc. | COM | 30048L104 | 4,033 | 1,425,000 | SH | | SOLE | | 1,425,000 | 0 | 0 |
Frequency Therapeutics, Inc. | COM | 35803L108 | 21,988 | 945,719 | SH | | SOLE | | 945,719 | 0 | 0 |
Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | 92,980 | 2,000,000 | SH | | SOLE | | 2,000,000 | 0 | 0 |
Fulgent Genetics, Inc. | COM | 359664109 | 9,111 | 569,444 | SH | | SOLE | | 569,444 | 0 | 0 |
Galapagos NV | SPON ADR | 36315X101 | 2,579 | 13,072 | SH | | SOLE | | 13,072 | 0 | 0 |
Galmed Pharmaceuticals Ltd. | SHS | M47238106 | 1,031 | 215,594 | SH | | SOLE | | 215,594 | 0 | 0 |
Gamida Cell Ltd. | SHS | M47364100 | 3,047 | 666,666 | SH | | SOLE | | 666,666 | 0 | 0 |
Genfit SA | ADS | 372279109 | 156 | 28,396 | SH | | SOLE | | 28,396 | 0 | 0 |
Global Blood Therapeutics, Inc. | COM | 37890U108 | 2,967 | 47,000 | SH | | SOLE | | 47,000 | 0 | 0 |
GW Pharmaceuticals plc | ADS | 36197T103 | 22,709 | 185,045 | SH | | SOLE | | 185,045 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 88,526 | 6,018,104 | SH | | SOLE | | 6,018,104 | 0 | 0 |
HOOKIPA Pharma Inc. | COM | 43906K100 | 8,140 | 700,481 | SH | | SOLE | | 700,481 | 0 | 0 |
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 11,116 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Idera Pharmaceuticals, Inc. | COM PAR | 45168K405 | 8,250 | 4,608,786 | SH | | SOLE | | 4,608,786 | 0 | 0 |
IGM Biosciences, Inc. | COM | 449585108 | 229,528 | 3,144,223 | SH | | SOLE | | 3,144,223 | 0 | 0 |
Immunomedics, Inc. | COM | 452907108 | 11,695 | 330,000 | SH | | SOLE | | 330,000 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 3,326,944 | 31,999,081 | SH | | SOLE | | 31,999,081 | 0 | 0 |
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 525 | 580,400 | SH | | SOLE | | 580,400 | 0 | 0 |
Inflarx N.V. | COM | N44821101 | 4,859 | 1,058,555 | SH | | SOLE | | 1,058,555 | 0 | 0 |
Insmed Incorporated | COM PAR $.01 | 457669307 | 83,319 | 3,025,384 | SH | | SOLE | | 3,025,384 | 0 | 0 |
Intellia Therapeutics, Inc. | COM | 45826J105 | 2,702 | 128,538 | SH | | SOLE | | 128,538 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 358,966 | 11,850,962 | SH | | SOLE | | 11,850,962 | 0 | 0 |
IVERIC bio, Inc. | COM | 46583P102 | 8,341 | 1,635,501 | SH | | SOLE | | 1,635,501 | 0 | 0 |
Karuna Therapeutics, Inc. | COM | 48576A100 | 9,137 | 81,976 | SH | | SOLE | | 81,976 | 0 | 0 |
Kezar Life Sciences, Inc. | COM | 49372L100 | 3,108 | 600,000 | SH | | SOLE | | 600,000 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 71,333 | 2,799,577 | SH | | SOLE | | 2,799,577 | 0 | 0 |
Kodiak Sciences Inc. | COM | 50015M109 | 626,414 | 11,574,538 | SH | | SOLE | | 11,574,538 | 0 | 0 |
Krystal Biotech, Inc. | COM | 501147102 | 33,866 | 817,631 | SH | | SOLE | | 817,631 | 0 | 0 |
Leap Therapeutics, Inc. | COM | 52187K101 | 2,045 | 978,454 | SH | | SOLE | | 978,454 | 0 | 0 |
Legend Biotech Corporation | SPONSORED ADS | 52490G102 | 5,746 | 135,000 | SH | | SOLE | | 135,000 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 169,786 | 1,499,212 | SH | | SOLE | | 1,499,212 | 0 | 0 |
Marker Therapeutics, Inc. | COM | 57055L107 | 498 | 240,505 | SH | | SOLE | | 240,505 | 0 | 0 |
Matinas BioPharma Holdings, Inc. | COM | 576810105 | 1,620 | 2,096,375 | SH | | SOLE | | 2,096,375 | 0 | 0 |
Merus N.V. | COM | N5749R100 | 32,783 | 2,037,469 | SH | | SOLE | | 2,037,469 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 160,955 | 1,409,784 | SH | | SOLE | | 1,409,784 | 0 | 0 |
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 11,352 | 583,333 | SH | | SOLE | | 583,333 | 0 | 0 |
Molecular Templates, Inc. | COM | 608550109 | 2,182 | 158,217 | SH | | SOLE | | 158,217 | 0 | 0 |
MyoKardia, Inc. | COM | 62857M105 | 305,728 | 3,164,234 | SH | | SOLE | | 3,164,234 | 0 | 0 |
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 56,402 | 3,397,740 | SH | | SOLE | | 3,397,740 | 0 | 0 |
Neurocrine Biosciences, Inc. | COM | 64125C109 | 110,652 | 906,986 | SH | | SOLE | | 906,986 | 0 | 0 |
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 2,456 | 124,400 | SH | | SOLE | | 124,400 | 0 | 0 |
Novavax, Inc. | COM | 670002401 | 20,119 | 241,376 | SH | | SOLE | | 241,376 | 0 | 0 |
Orchard Therapeutics plc | ADS | 68570P101 | 2,434 | 405,702 | SH | | SOLE | | 405,702 | 0 | 0 |
Ovid Therapeutics Inc. | COM | 690469101 | 3,377 | 458,253 | SH | | SOLE | | 458,253 | 0 | 0 |
Oyster Point Pharma, Inc. | COM | 69242L106 | 2,063 | 71,428 | SH | | SOLE | | 71,428 | 0 | 0 |
Passage Bio, Inc. | COM | 702712100 | 7,516 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
Principia Biopharma Inc. | COM | 74257L108 | 94,520 | 1,580,873 | SH | | SOLE | | 1,580,873 | 0 | 0 |
Protagonist Therapeutics, Inc. | COM | 74366E102 | 33,756 | 1,911,446 | SH | | SOLE | | 1,911,446 | 0 | 0 |
Protara Therapeutics, Inc. | COM STK | 74365U107 | 5,854 | 199,671 | SH | | SOLE | | 199,671 | 0 | 0 |
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 8,734 | 55,983 | SH | | SOLE | | 55,983 | 0 | 0 |
Replimune Group, Inc. | COM | 76029N106 | 128 | 5,141 | SH | | SOLE | | 5,141 | 0 | 0 |
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 60,211 | 2,700,055 | SH | | SOLE | | 2,700,055 | 0 | 0 |
Sangamo Therapeutics, Inc. | COM | 800677106 | 8,958 | 999,823 | SH | | SOLE | | 999,823 | 0 | 0 |
Seattle Genetics, Inc. | COM | 812578102 | 8,032,021 | 47,269,424 | SH | | SOLE | | 47,269,424 | 0 | 0 |
Sunesis Pharmaceuticals, Inc. | COM | 867328700 | 147 | 556,665 | SH | | SOLE | | 556,665 | 0 | 0 |
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 7,357 | 690,167 | SH | | SOLE | | 690,167 | 0 | 0 |
Tricida, Inc. | COM | 89610F101 | 21,643 | 787,582 | SH | | SOLE | | 787,582 | 0 | 0 |
uniQure N.V. | SHS | N90064101 | 10,404 | 230,883 | SH | | SOLE | | 230,883 | 0 | 0 |
Urovant Sciences Ltd. | SHS | G9381B108 | 9,840 | 1,000,000 | SH | | SOLE | | 1,000,000 | 0 | 0 |
Vaxart, Inc. | COM | 92243A200 | 14,506 | 1,639,121 | SH | | SOLE | | 1,639,121 | 0 | 0 |
Viking Therapeutics, Inc. | COM | 92686J106 | 3,064 | 425,000 | SH | | SOLE | | 425,000 | 0 | 0 |
Xencor, Inc. | COM | 98401F105 | 13,867 | 428,120 | SH | | SOLE | | 428,120 | 0 | 0 |
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 10,021 | 799,102 | SH | | SOLE | | 799,102 | 0 | 0 |
Zymeworks Inc. | COM | 98985W102 | 61,625 | 1,708,472 | SH | | SOLE | | 1,708,472 | 0 | 0 |
BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | 18,340 | 15,000,000 | PRN | | SOLE | | 15,000,000 | 0 | 0 |
Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | 51,144 | 30,770,000 | PRN | | SOLE | | 30,770,000 | 0 | 0 |